I’ve (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer and here to stay, I hope this aids in your due diligence efforts.
- Quick reads to get you up to speed:
- Investor Presentaion 2020 NEW
- Summary of the current situation and opportunity by jckrdu
- Reddit link to above post where you can post comments
- Basic info for newcomers post by shnozzletop
- Barda process overview by CavScout1969
- Top resources for information and due diligence:
- Read all recent Wall Street Titan Articles on Seeking Alpha
- ATHX Reddit: use the search feature and most likely your question has already been discussed here
- Athersys website: for PRs, Pipeline, SEC filings, etc.
- Healios website: for PRs, Quarterly reports, Pipeline
- Nikon Cell Innovation: Manufacturing Partner in Japan
- Multistem trials on clinicaltrials.gov
- Lancet Article: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
- BiotechInvestor ATHX Forum
- Athersys YouTube page
- Athersys Twitter page
- StockTwits $ATHX for day trader tweets
- Yahoo Finance ATHX message board
- Thought Leadership:
- Athersys Is Poised To Snatch The Holy Grail Of Acute Injury by Vision and Value
- Most important Investors Facts #1 #2 by Gibis1
- Dreaming BIG… by wisdom_man1
- Why Mulitstem in stroke has such a huge potential by cmyepb
- The Big Picture Perspective by gibis1
- Investment Check by wisdom_man1
- Investor Meetings:
- NYC Investor Conference Part 1 & Part 2 & Part 3 & Part 4 & Part 5 & Part 6 and Part 7 by rootingforathx
- Notes from 2019 ShareHolders meeting Part 1 & Part 2 and Part 3 by Gibis1
- Investors Day – additional perspective by RealNiceKeith
- Analyst Coverage:
- WB Report and WB Report ARDS by crushlikeaboss
- Dawson James Report by wisdom_man1
- Trial coverage from Principal Investigators:
- ARDS: Dr. Geoff Bellingan: The Future for Multi-Stem Cell Therapy
- Stroke: Author Interview: Dr. Sean Savitz, MD, on “Intravenous Cellular Therapies for Acute Ischemic Stroke”
- Stroke: Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury by David Hess et al
- Stroke: A double‐blind placebo‐controlled clinical evaluation of MultiStem for the treatment of ischemic stroke by David Hess et al
